Essential thrombocythaemia in children
Yigal Dror,
Victor S. Blanchette,
Yigal Dror
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorVictor S. Blanchette
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorYigal Dror,
Victor S. Blanchette,
Yigal Dror
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorVictor S. Blanchette
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada
Search for more papers by this authorDr Yigal Dror, Division of Paediatric Haematology/Oncology, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel.
References
- 1 Amato, D. & Freedman, M.H. (1984) Eleven-year follow-up of primary thrombocythemia in a child. Journal of Pediatrics, 104, 639.
- 2 Anagrelide Study Group (1992) Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. American Journal of Medicine, 92, 69–76.DOI: 10.1016/0002-9343(92)90017-6
- 3 Barbui, T., Buelli, M., Cortelazzo, S., Viero, P. & De Gaetano, G. (1987) Aspirin and risk of bleeding in patients with thrombocythemia. American Journal of Medicine, 83, 265–268.
- 4 Barbui, T., Cortelazzo, S., Viero, P., Bassan, R., Dini, E. & Semeraro, N. (1983) Thrombohaemorrhagic complication in 101 cases of myeloproliferative disorders: relationship to platelet number and function. European Journal of Cancer and Clinical Oncology, 19, 1593–1599.
- 5 Barnhart, M.I., Kim, T.H., Evatt, B.L., Ragab, A.H., Lui, V.K. & Lusher, J.M. (1980) Essential thrombocythemia in a child: platelet ultrastructure and function. American Journal of Hematology, 8, 87–107.
- 6 Berk, P.D., Goldberg, J.D., Silverstein, M.N., Weinfeld, A., Donovan, P.B., Ellis, J.T., Landaw, S.A., Laszlo, J., Najean, Y., Pisciota, A.V. & Wasserman, L.R. (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. New England Journal of Medicine, 304, 441–447.
- 7 Beressi, A.H., Tefferi, A., Silverstein, M.N., Petitt, R.M. & Hoagland, H.C. (1995) Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Archives of Internal Medicine, 155, 1217–1222.
- 8
Bucalossi, A.,
Marotta, G.,
Bigazzi, C.,
Galieni, P. &
Dispensa, E. (1996) Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
American Journal of Hematology, 52, 14–20.
10.1002/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- 9 Case, D.C. (1984) Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood, 63, 51–54.
- 10 Chintagumpala, M.M., Steuber, C.P., Mahoney, D.H., Ogden, A.K. & Fernbach, D.J. (1991) Essential thrombocythemia in a child: management with anagrelide. American Journal of Pediatric Hematology and Oncology, 13, 52–56.
- 11 Cohen, N., Almozlino-Sarafian, D., Weissgarten, J., Alon, I., Zaidenstein, R., Dishi, V., Rahimi-Levne, N., Fried, K. & Golik, A. (1997) Benign familial microcytic thrombocytosis with autosomal dominant transmission. Clinical Genetics, 52, 47–50.
- 12 Cohen-Solal, K., Villeval, J.L., Titeux, M., Lok, S., Vainchenker, W. & Wendling, F. (1996) Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood, 88, 2578–2584.
- 13
Colombi, M.,
Radaelli, F.,
Zocchi, L. &
Maiolo, A.T. (1991) Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients.
Cancer, 67, 2926–2930.
10.1002/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3 PubMed Web of Science® Google Scholar
- 14 Cortelazzo, S., Barbui, T., Bassan, R. & Dini, E. (1980) Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thrombosis and Haemostasis, 43, 127–130.
- 15 Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F. & Barbui, T. (1995) Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. New England Journal of Medicine, 332, 1132–1136.
- 16 Cortelazzo, S., Viero, P., Finazzi, G., Di'emilio, A., Rodeghiero, F. & Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology, 8, 556–562.
- 17 Dror, Y., Gelman-Kohan, Z., Hagai, Z., Juster-Reichter, A., Nisani-Ben Cohen, R. & Mogilner, B. (1994) Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acethylcholinesterase electrophoretic band. American Journal of Perinatology, 11, 149–153.
- 18 Dror, Y., Zipursky, A. & Blanchette, V.S. (1999) Essential thrombocythemia in children. Journal of Pediatric Hematology/Oncology, in press.
- 19 Eyster, M.E., Saletan, S.L., Rabellino, E.M., Karanas, A., McDonald, T.P., Locke, L.A. & Luderer, J.R. (1986) Familial essential thrombocythemia. American Journal of Medicine, 80, 497–502.DOI: 10.1016/0002-9343(86)90727-8
- 20 Falconer, J., Pineo, G., Blahey, W., Bowen, T., Docksteader, B. & Jadusingh, I. (1987) Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. American Journal of Hematology, 25, 345–347.
- 21
Fenaux, P.,
Simon, M.,
Lai, J.L.,
Goudemand, J. &
Bauters, F. (1990) Clinical course of essential thrombocythemia in 147 cases.
Cancer, 66, 549–556.
10.1002/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6 PubMed Web of Science® Google Scholar
- 22 Fernandez-Robles, E., Vermylen, C., Martiat, P., Ninane, J. & Cornu, G. (1990) Familial essential thrombocythemia. Pediatric Hematology/Oncology, 7, 373–376.
- 23 Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K. & Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 58, 916–919.
- 24 Fickers, M. & Speck, B. (1974) Thrombocythaemia. Acta Haematologica, 51, 257–265.
- 25 Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K. & De Sauvage, F.J. (1996) Regulation of thrombopoietin levels by c-mpl mediated binding to platelets. Blood, 87, 2154–2161.
- 26 Florensa, L., Besses, C., Almarcha, J., Lafuente, R., Palou, L., Pedro, C., Sans-Sabrafen, J. & Woessner, S. (1989) Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia. European Journal of Haematology, 43, 417–422.
- 27 Freedman, M.H., Olivares, R.S. & McClure, P.D. (1973) Primary thrombocythemia in a child. Journal of Pediatrics, 83, 163–167.
- 28 Genderen, P.J.J. & Michiels, J.J. (1995) Hydroxyurea in essential thrombocythemia. New England Journal of Medicine, 333, 802–803.DOI: 10.1056/NEJM199509213331216
- 29 Harrison, C.N., Gale, R.E., Machin, S.J. & Linch, D.C. (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood, 93, 417–424.
- 30 Heath, H.W. & Pearson, H.A. (1989) Thrombocytosis in pediatric outpatients. Journal of Pediatrics, 114, 805–807.
- 31
Hehlmann, R.,
Jahn, M.,
Baumann, B. &
Kopcke, W. (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases.
Cancer, 61, 2487–2496.
10.1002/1097-0142(19880615)61:12<2487::AID-CNCR2820611217>3.0.CO;2-T PubMed Web of Science® Google Scholar
- 32
Hermann, J.,
Fuchs, D.,
Sauerbrey, A.,
Hempel, L. &
Zintl, F. (1998) Successful treatment of essential thrombocythemia with anagrelide in a child.
Medical and Pediatric Oncology, 30, 367–371.DOI: 10.1002/(SICI)1096-911X(199806)30:6<367::AID-MPO13>3.0.CO;2-F
10.1002/(SICI)1096-911X(199806)30:6<367::AID-MPO13>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 33 Hirayama, Y., Sakamaki, S., Matsunaga, T., Kuga, T., Kuroda, H., Kusakabe, T., Sasaki, K., Fujikawa, K., Kato, J., Kogawa, K., Koyama, R. & Niitsu, Y. (1998) Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood, 92, 46–52.
- 34 Hoagland, H.C. & Silverstein, M.N. (1978) Primary thrombocythemia in the young patient. Mayo Clinic Proceedings, 53, 578–580.
- 35 Hoffman, R. & Wasserman, L.R. (1979) Natural history and management of polycythemia vera. Advances in Internal Medicine, 24, 255–285.
- 36 Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. & Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood, 90, 4031–4038.
- 37 Host, N.B. & Saunamaki, K.I. (1992) Coronary heart disease in young age associated with essential thrombocythemia. American Heart Journal, 124, 219–221.DOI: 10.1016/0002-8703(92)90945-R
- 38 Juvonen, E., Ikkala, E., Oksanen, K. & Ruutu, T. (1993) Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. British Journal of Haematology, 83, 192–197.
- 39 Kaplan, M.E., Mack, K., Goldberg, J.D., Donovan, P.B., Berk, P.D. & Wasserman, L.R. (1987) Long-term management of polycythemia vera with hydroxyurea: a progress report. Seminars in Hematology, 23, 167–171.
- 40 Kapoor, G., Correa, H. & Yu, L.C. (1996) Essential thrombocythemia in an infant. Journal of Pediatric Hematology/Oncology, 18, 381–383.DOI: 10.1097/00043426-199611000-00009
- 41 Kessler, C.M., Klein, H.G. & Havlik, R.J. (1982) Uncontrolled thrombocytosis in chronic myeloproliferative disorders. British Journal of Haematology, 50, 157–167.
- 42 Kikawa, Y., Fukumoto, Y., Obata, K., Tamura, S., Takeuchi, M., Tanizawa, A. & Mayumi, M. (1998) Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha. Journal of Pediatric Hematology/Oncology, 20, 463–466.DOI: 10.1097/00043426-199809000-00010
- 43 Kikuchi, M., Tayama, T., Hayakawa, H., Takahashi, I., Hoshino, H. & Ohsaka, A. (1995) Familial thrombocytosis. British Journal of Haematology, 89, 900–902.
- 44 Kiladjian, J.J., Elkassar, N., Hetet, G., Briere, J., Grandchamp, B. & Gardin, C. (1997) Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia, 11, 1821–1826.DOI: 10.1038/sj.leu.2400845
- 45 Kondo, T., Okabe, M., Sanada, M., Kurosawa, M., Suzuki, S., Kobayashi, M., Hosokawa, M. & Asaka, M. (1998) Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood, 92, 1091–1096.
- 46 Kunishima, S., Mizuno, S., Naoe, T., Saito, H. & Kamiya, T. (1998) Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia: a case study. British Journal of Haematology, 100, 383–386.DOI: 10.1046/j.1365-2141.1998.00571.x
- 47 Lackner, H., Urban, C., Beham-Schmid, C., Benesch, M., Kerbl, R. & Schwinger, W. (1998) Treatment of children with anagrelide for thrombocythemia. Journal of Pediatric Hematology/Oncology, 20, 469–473.DOI: 10.1097/00043426-199809000-00012
- 48
Lahuerta-Palacios, J.J.,
Borstein, R.,
Fernandez-Debora, F.J.,
Gutierrez-Rivas, E.,
Ortis, M.C.,
Larregla, S.,
Calandre, L. &
Montero-Castillo, J. (1988) Controlled and uncontrolled thrombocytosis: its clinical role in essential thrombocythemia.
Cancer, 61, 1207–1212.
10.1002/1097-0142(19880315)61:6<1207::AID-CNCR2820610625>3.0.CO;2-4 PubMed Web of Science® Google Scholar
- 49 Linch, D.C., Hutton, R., Cowan, D., Moore, A.R., Richards, J.D.M. & Wilkinson, L.S. (1982) Primary thrombocythaemia in childhood. Scandinavian Journal of Haematology, 28, 72–76.
- 50 Lumley, S.E. (1971) Essential thrombocythaemia in childhood. Proceedings of the Royal Society of Medicine, 64, 22–23.
- 51 McIntyre, K.J., Hoagland, H.C., Silverstein, M.N. & Petitt, R.M. (1991) Essential thrombocythemia in young adults. Mayo Clinic Proceedings, 66, 149–154.
- 52 Mercer, B., Drouin, J., Jolly, E. & D'anjou, G. (1988) Primary thrombocythemia in pregnancy: a report of two cases. American Journal of Obstetetrics and Gynecology, 159, 127–128.
- 53 Mertens, F., Johansson, B., Heim, S., Kristoffersson, U. & Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia, 5, 214–220.
- 54 Michiels, J.J. & Van Genderen, P.J. (1997) Essential thrombocythemia in childhood. Seminars in Thrombosis and Hemostasis, 23, 295–301.
- 55 Mitus, A.J., Barbui, T., Shulman, L.N., Rosenthal, D.S., Viero, P., Cortelazzo, S. & Schaffer, A.I. (1990) Hemostatic complications in young patients with essential thrombocythemia. American Journal of Medicine, 88, 371–375.DOI: 10.1016/0002-9343(90)90491-U
- 56 Mughal, T.I. (1995) Primary thrombocythemia: a current prospective. Stem Cell, 13, 355–359.
- 57 Murphy, S., Peterson, P., Iland, H. & Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 29–39.
- 58
Nand, S.,
Stock, W.,
Godwin, J. &
Fisher, S.G. (1996) Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis.
American Journal of Hematology, 52, 42–46.DOI: 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6
10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
- 59 Ozer, F.L., Wayne, E.T., Miech, D.C. & Levin, W.C. (1960) Primary hemorrhagic thrombocythemia. American Journal of Medicine, 28, 807–823.DOI: 10.1016/0002-9343(60)90136-4
- 60 Pogliani, E.M., Rossini, F., Miccolis, I., Ferrario, A., Perego, D., Casaroli, I., Bolis, S., Fagnani, D., Brabilla, M. & Corneo, G. (1995) Alpha-interferon as initial treatment of essential thrombocythemia: analysis after two years of follow-up. Tumori, 81, 245–248.
- 61 Sceats, D.J. & Baitlon, D. (1980) Primary thrombocythemia in a child. Clinical Pediatrics, 19, 298–300.
- 62 Schlemper, R.J., Van Der Maas, A.P.C. & Eikenboom, J.C.J. (1994) Familial essential thrombocythemia: clinical characteristics of 11 cases in one family. Annals of Hematology, 68, 153–158.
- 63 Sedlaceck, S.M., Curtis, J.L., Weintraub, J. & Levin, J. (1986) Essential thrombocythemia and leukemic transformation. Medicine, 65, 353–364.
- 64 Seewan, H.L., Zikulnig, R. & Gallhofer, G. (1991) Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b. European Journal of Cancer, 27, (Suppl.), 58–68.
- 65 Silverstein, M.N., Petitt, R.M., Solberg, L.A., Jr, Fleming, J.S., Knight, R.C. & Schacter, L.P. (1988) Anagrelide: a new drug for treating thrombocytosis. New England Journal of Medicine, 318, 1291–1294.
- 66 Slee, P.H., Van Everdingen, J.J.E., Geraedts, J.P.M., Velde, J. & Den Ottolander, G.J. (1981) Familial myeloproliferative disease: hematological and cytogenetic studies. Acta Medica Scandinavica, 210, 321–327.
- 67 Snethlage, W. & Ten Cate, J.W. (1986) Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment: case report. British Journal of Obstetrics and Gynaecology, 93, 386–388.
- 68 Spach, M.S., Howell, D.A. & Harris, J.S. (1963) Myocardial infarction and multiple thromboses in a child with primary thrombocytosis. Pediatrics, 31, 268–276.
- 69 Spencer, C.M. & Brogden, R.N. (1994) Anagrelide: a review of its pharmacodynamic properties and therapeutic potential in the treatment of thrombocythemia. Drugs, 47, 809–822.
- 70 Sterkers, Y., Preudhomme, C., Lai, J.L., Demory, J.L., Caulier, J.L., Wattel, E., Bordessoule, D., Bauters, F. & Fenaux, P. (1998) Acute myeloid leukemia and myelodysplastic syndrome following essential thrombocythaemia, treated with hydroxyurea: high proportion of cases with 17p deletion. Blood, 91, 616–622.
- 71 Taksin, A.L., Couedic, J.P.L., Dusanter-Fourt, I., Masse, A., Giraudier, S., Katz, A., Wendling, F., Vainchenker, W., Casadevall, N. & Debili, N. (1999) Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by mpl-L. Blood, 93, 125–139.
- 72 Tartaglia, A.P., Goldberg, J.D., Berk, P.D. & Wasserman, L.R. (1986) Adverse effect of antiaggregating platelet therapy in the treatment of polycythemia vera. Seminars in Hematology, 23, 172–176.
- 73 Tefferi, A. & Hoagland, H.C. (1994) Issues in the diagnosis and management of essential thrombocythemia. Mayo Clinic Proceedings, 69, 651–655.
- 74 Thornley, S. & Manoharan, A. (1994) Successful treatment of essential thrombocythemia with alpha interferon during pregnancy. European Journal of Haematology, 52, 63–64.
- 75 Van Dijken, P.J., Woldendrop, K.H. & Van Wouwe, J.P. (1996) Familial thrombocytosis in infancy presenting with leukemoid reaction. Acta Paediatrica, 85, 1132–1134.
- 76 Vora, A.J. & Lilleyman, J.S. (1993) Secondary thrombocytosis. Archives of Diseases of Childhood, 68, 88–90.
- 77 Watanabe, K., Takeuuchi, K., Kawai, Y., Ikeda, F., Kubota, F. & Nakamoto, H. (1995) Automated measurement of reticulated platelets in estimating thrombopoiesis. European Journal of Haematology, 54, 163–171.
- 78 Weinfeld, A., Swolin, B. & Westin, J. (1994) Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: prospective study of efficacy and leukemogenicity with therapeutic implications. European Journal of Haematology, 52, 134–139.
- 79 Wiestner, A., Schlemper, R.J., Van Der Maas, A.P. & Skoda, R.C. (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nature Genetics, 18, 49–52.DOI: 10.1038/ng0198-49
- 80 Williams, E.C. & Shahidi, N.T. (1991) Benign familial thrombocytosis. American Journal of Hematology, 37, 124–125.
- 81 Zaccaria, A. & Tura, S. (1978) A chromosomal abnormality in primary thrombocythemia. New England Journal of Medicine, 298, 1422–1423.
- 82 Yoshida, N., Ishii, E., Koga, N., Kamimura, T. & Miyazaki, S. (1998) Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia. Pediatric Hematology/Oncology, 15, 359–363.
Citing Literature
